Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992869priorityCriticalpatent/ECSP992869A/en
Publication of ECSP992869ApublicationCriticalpatent/ECSP992869A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Inhibidores del NHE-1, métodos de uso de dichos inhibidores del NHE-1 y composiciones farmacéuticas que contienen dichos inhibidores del NHE-1, los inhibidores del NHE-1 son útiles para la reducción del daño en el tejido como consecuencia de izquemia en el tejido.NHE-1 inhibitors, methods of using said NHE-1 inhibitors, and pharmaceutical compositions containing such NHE-1 inhibitors, NHE-1 inhibitors are useful for reducing tissue damage as a consequence of izchemia in the tissue.
ECSP9928691999-02-251999-02-25
COMPOUNDS FOR THE TREATMENT OF IZCHEMIA
ECSP992869A
(en)
ANALOG COMPOUNDS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL, PROCESS FOR PREPARATION, USE IN THE TREATMENT OF VIRAL INFECTIONS, AND PACKING THAT CONTAINS THEM
PREVENTION AND TREATMENT OF HYPERTENSIVE CARDIAC DISEASES THROUGH THE USE OF SELECTIVE STROGENS 8BETA-VINIL-ESTRA-1,3,5 (10) -TRIEN-3,17BETA-DIOL AND 17BETA-FLUOR-9ALFA-VINIL-ESTRA-1.3,5 (10) -TRIEN-3.16ALFA-DIOL